AlloVir, Inc. - Common Stock (NQ: ALVR )
9.900
+0.020
(+0.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about AlloVir, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13619.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/28/image39.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13514.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/27/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/27/image29_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/27/biotech3.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From AlloVir, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12407.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220607005523/en/841466/5/AlloVir_Logo_FullColor%5B2%5D%5B2%5D%5B9%5D.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9650.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/13/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/12/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220505005395/en/841466/5/AlloVir_Logo_FullColor%5B2%5D%5B2%5D%5B9%5D.jpg)
AlloVir Reports First Quarter 2022 Financial Results
May 05, 2022
From AlloVir, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7489.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7473.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/mid-day-market-update.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/25/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/mid-day_movers_image.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/21/yesterdays_movers.png)
![](https://investorplace.com/wp-content/uploads/2020/06/fda-food-drug.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/mid-morning-market-update.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/laboratory-gacf4d94ac_1920.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6878.jpeg)
![](https://mms.businesswire.com/media/20220420005069/en/841466/5/AlloVir_Logo_FullColor%5B2%5D%5B2%5D%5B9%5D.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_5775.jpeg)
![](https://mms.businesswire.com/media/20220331005369/en/841466/5/AlloVir_Logo_FullColor%5B2%5D%5B2%5D%5B9%5D.jpg)
AlloVir Appoints Shawn Tomasello to Its Board of Directors
March 31, 2022
From AlloVir
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.